Webinar - Bioanalysis by Hybridization ELISA for Antisense Oligonucleotides

Поділитися
Вставка
  • Опубліковано 20 лип 2024
  • In this webinar, Altasciences' Dr. Danielle Salha, Senior Director, Ligand Binding Assays, presents how hybridization ELISA can be an effective approach to quantify antisense oligonucleotides in circulation and in their targeted tissue.
    Topics covered:
    - The advantages and limitations of hybridization ELISA
    - The different types of hybridization ELISAs and how to choose the right format
    - The possible platforms to use for hybridization ELISA
    - The common bioanalytical issues encountered and mitigation plans
    - The most common challenges encountered with different matrices and tissues
    We offer a full range of bioanalytical services conducted in state-of-the-art, purpose-built laboratories at our locations in the U.S. and Canada, with designated containment Level 2 areas for work with Risk Group 2 pathogens. Staffed by highly-skilled analysts, and shifts running 24/7 (as needed), we can process over 60,000 study samples per month. Precision bioanalytical services are available as stand-alone, or part of a package of services.
    Our team of dedicated bioanalytical scientists works with the latest equipment to provide bioanalytical services from discovery to preclinical and clinical pharmacology, in accordance with GLP and current FDA/EMA guidelines for both small and large molecules, including immunogenicity and biomarkers. Each bioanalytical validation and bioanalytical phase for sample analysis has an assigned Bioanalytical Principal Investigator.
    Altasciences is an integrated drug development solution company, offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to their preclinical and clinical study needs. From lead candidate selection to proof of concept, we offer one-stop integrated formulation, preclinical and clinical manufacturing and analytical services. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements.
    Altasciences… helping sponsors get better drugs to the people who need them, faster. Visit our website to learn more: www.altasciences.com/bioanaly...
    #Altasciences #ScientificResearch #Pharmacology
  • Наука та технологія

КОМЕНТАРІ •